Skip to main content
. 2021 Oct 20;12:732874. doi: 10.3389/fphar.2021.732874

FIGURE 1.

FIGURE 1

(A) HBMECs were treated with quercetin (0, 0.1, 0.5, 1, 2, 5, 10 μmol/L) for 24 h, viability was measured using CCK-8 method (B) HBMECs were treated with quercetin (0, 0.1, 0.5, 1, 2, 5, 10 μmol/L) and H/R treatment, viability was measured using CCK-8 method. ### p < 0.001 compared to control group; ** p < 0.01, *** p < 0.001 compared to H/R group. H/R: hypoxia and reoxygenation, n = 3.